 |
 |
I don't think so. In this procedure, tissue is destroyed. On 22 September 2011 13:43, mschild <[log in to unmask]> wrote: > Insightec reports success in Parkinson's study > The company's noninvasive focused ultrasound ExAblate Neuro system is > designed > to treat chronic neurological disorders. > 21 September 11 12:00, Globes' correspondent > inShare2 > > InSightec Ltd. today reported success in a clinical trial of its > noninvasive > focused ultrasound ExAblate Neuro system to treat chronic neurological > disorders. The trial of 30 patients in Switzerland and the US tested the > device's safety and initial efficacy in the treatment of essential tremor, > neuropathic pain and Parkinson’s disease. ExAblate Neuro is the first > clinical > system to use MR guided focused ultrasound through an intact skull, > combining > focused ultrasound and real time MR guidance and control, to treat tissue > deep > in the brain without incisions or cutting or ionizing radiation. The system > is > limited to investigational use. > InSightec will conduct more trials to evaluate the technology's ability to > reduce the risk of complications and side-effects, and to see whether it > could > provide treatment for individuals for whom surgery is currently not an > option, > or refuse an intervention of the brain. InSightec plans to additional > clinical > trials of the ExAblate Neuro for brain tumors, stroke and targeted drug > delivery to the brain. > InSightec VP of R&D Eyal Zadicario said, "The concept of using focused > ultrasound for non-invasive treatment of brain disorders has been > recognized > for many years, however, vast technical barriers had to be overcome to > enable > this modality to become a reality." He added, "ExAblate Neuro has > demonstrated > the ability to ablate targets deep in the brain with high precision. The > initial results have been encouraging. This gives us hope that this > treatment > alternative could in the future become a significant addition to the > physicians’ armamentarium in treating functional brain diseases." > For patients who do not respond to drug treatments for neurological > disorders, > procedures include deep brain stimulation, radiofrequency ablation, > radiosurgery which are either invasive or involve ionizing radiation. These > are associated with recognized risks: either high doses of ionizing > radiation > or high risk of complications and side effects. > Mordechay Zisser controls Insightec through Elbit Imaging Ltd. (Nasdaq: > EMITF; > TASE: EMIT) subsidiary Elbit Medical Technologies Ltd. (TASE:EMTC). Elbit > Imaging rose 8.2% on Nasdaq yesterday to $2.37, giving a market cap of $60 > million, and rose 3.3% by midday on the TASE today to NIS 8.42. Elbit > Medical's share price rose 0.6% to NIS 0.17, giving a market cap of NIS 132 > million. > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto: > [log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn